<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The incidence of thromboembolic complications (TE) during pregnancy in women with congenital antithrombin III (AT) deficiency has retrospectively been estimated to be about 70% </plain></SENT>
<SENT sid="1" pm="."><plain>8 women with congenital AT deficiency were studied during 9 pregnancies </plain></SENT>
<SENT sid="2" pm="."><plain>Subcutaneous or intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi> in doses to prolong the activated partial thromboplastin time (APTT) was given during pregnancy as prophylaxis or therapeutic treatment </plain></SENT>
<SENT sid="3" pm="."><plain>During delivery and abortion the AT level was brought to <z:mpath ids='MPATH_458'>normal</z:mpath> by infusion of AT concentrate and the <z:chebi fb="5" ids="28304">heparin</z:chebi> was reduced or withdrawn </plain></SENT>
<SENT sid="4" pm="."><plain>Four pregnancies were uncomplicated with regard to TE and resulted in 4 healthy children </plain></SENT>
<SENT sid="5" pm="."><plain>Five pregnancies were terminated by induced or <z:hpo ids='HP_0005268'>spontaneous abortion</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>1 woman had TE during <z:chebi fb="5" ids="28304">heparin</z:chebi> prophylaxis and 2 women had TE before the prophylaxis was started </plain></SENT>
<SENT sid="7" pm="."><plain>1 of the latter suffered from a new TE during continued heparing treatment </plain></SENT>
<SENT sid="8" pm="."><plain>Insufficient prolongation of APTT was registered at the time of TE in both women with TE during <z:chebi fb="5" ids="28304">heparin</z:chebi> treatment </plain></SENT>
</text></document>